CRS is disabling and is associated with high direct and indirect costs, yet little is known about the epidemiology, etiologic heterogeneity, and individual and societal burden. There is a substantial gap in understanding how to frame research needs for CRS and improve patient outcomes. This project will complete a large-scale epidemiologic study of CRS by leveraging the unique data and population assets of the Geisinger Clinic, including a primary care population of 400,000 patients in over 30 counties in Pennsylvania. We will combine longitudinal self-reported and electronic health record data with new clinical and research measurements to address gaps in understanding. While relatively little is known about the natural history of CRS, it is clear that: many patients in the general population have nasal and sinus symptoms;some of these patients are diagnosed with allergic rhinitis or episodes of ARS (symptoms for 7d to 4wk, to eliminate patients with the common cold);some of these patients progress to CRS with symptoms present for at least 12 weeks;many patients with CRS have episodes of exacerbations, with a prominent worsening of symptoms over the baseline;many patients, especially those seen in tertiary centers, have recalcitrant CRS;and the natural history must include some therapeutic and probably spontaneous remissions. The incidence, prevalence, transition rates, and risk factors for each ofthe steps in the framework are not well known. Since relatively little research exists in population-based samples, it is likely that most studies have focused on patients who have failed therapy, the recalcitrant group. In the proposed research, we will estimate CRS prevalence, incidence, and remission using clinically validated criteria for general population samples that represent the full spectrum of CRS;describe patterns of CRS exacerbation and remission and the factors that explain variability;determine how CRS with and without nasal polyps cases differ from each other;evaluate a variety of community environmental risk factors for CRS using existing geospatial data on key environmental conditions;and estimate the direct and indirect costs of CRS.

Public Health Relevance

Chronic rhinosinusitis is a common condition that can cause severe symptoms in patients. It involves inflammation ofthe paranasal sinuses that results in facial pain/pressure, nasal and sinus drainage, smell loss, and nasal obstruction. Little is known however about how many people have the condition, who gets it, why they get it, and the best ways to treat it. The proposed research will address many of these issues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI106683-01
Application #
8592168
Study Section
Special Emphasis Panel (ZAI1-LAR-I (M2))
Project Start
Project End
Budget Start
2013-08-05
Budget End
2014-07-31
Support Year
1
Fiscal Year
2013
Total Cost
$559,165
Indirect Cost
$100,992
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Adams, Dara R; Kern, David W; Wroblewski, Kristen E et al. (2018) Olfactory Dysfunction Predicts Subsequent Dementia in Older U.S. Adults. J Am Geriatr Soc 66:140-144
Cole, M; Bandeen-Roche, K; Hirsch, A G et al. (2018) Longitudinal evaluation of clustering of chronic sinonasal and related symptoms using exploratory factor analysis. Allergy 73:1715-1723
Kuiper, J R; Hirsch, A G; Bandeen-Roche, K et al. (2018) Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis status. Allergy 73:1244-1253
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8
Chiu, Brandon L; Pinto, Jayant M (2018) Aging in the United States: Opportunities and Challenges for Otolaryngology-Head and Neck Surgery. Otolaryngol Clin North Am 51:697-704
Yang, Hyo J; LoSavio, Phillip S; Engen, Phillip A et al. (2018) Association of nasal microbiome and asthma control in patients with chronic rhinosinusitis. Clin Exp Allergy 48:1744-1747
Min, Jin-Young; Ocampo, Christopher J; Stevens, Whitney W et al. (2017) Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase. J Allergy Clin Immunol 139:130-141.e11
Pinto, Jayant M; Wroblewski, Kristen E; Huisingh-Scheetz, Megan et al. (2017) Global Sensory Impairment Predicts Morbidity and Mortality in Older U.S. Adults. J Am Geriatr Soc 65:2587-2595
Lidder, Alcina K; Detwiller, Kara Y; Price, Caroline P E et al. (2017) Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis. Int Forum Allergy Rhinol 7:128-134
Hirsch, A G; Stewart, W F; Sundaresan, A S et al. (2017) Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy 72:274-281

Showing the most recent 10 out of 60 publications